眼科器械龙头爱博医疗（688050）拟通过并购切入运动医学领域。在前次披露投资意向一个月后，公司于2月26日发布具体 收购方案，拟以6.83亿元收购德美联合（重庆）医疗科技有限公司（以下简称"德美医疗"）68.31%股权。交易作价较净资 产账面值溢价约3倍，预计将形成约5亿元商誉。资金方面，约70%至80%来自银行并购贷款。 针对市场对杠杆收购的关注，爱博医疗相关负责人于2月26日向北京商报记者回应称，目前公司账面自有资金较为充裕，回 款情况良好，且国家对并购贷款有相应的支持政策，合理使用财务杠杆不会构成较大压力。 近年来，德美医疗所处的运动医学赛道发展迅速。经营数据显示，2025年，德美医疗营收和净利润均实现较快增长。在当 前爱博医疗业绩增速放缓的背景下，此次收购能否为公司注入新的增长动力，记者将持续关注。 贷款比例预计为70%—80% 爱博医疗最新公告显示，公司拟使用并购贷款及自有资金收购德美医疗68.31%股权，本次交易对价为6.83亿元。公司支付 第一期股转款后，本次交易涉及的德美医疗股权将全部完成办理工商变更登记，公司将享有作为目标公司股东的全部权利 和权益，德美医疗将成为公司控股子公司，纳入公司合 ...

眼科器械龙头爱博医疗（688050）拟通过并购切入运动医学领域。在前次披露投资意向一个月后，公司于2月26日发布具体 收购方案，拟以6.83亿元收购德美联合（重庆）医疗科技有限公司（以下简称"德美医疗"）68.31%股权。交易作价较净资 产账面值溢价约3倍，预计将形成约5亿元商誉。资金方面，约70%至80%来自银行并购贷款。 针对市场对杠杆收购的关注，爱博医疗相关负责人于2月26日向北京商报记者回应称，目前公司账面自有资金较为充裕，回 款情况良好，且国家对并购贷款有相应的支持政策，合理使用财务杠杆不会构成较大压力。 近年来，德美医疗所处的运动医学赛道发展迅速。经营数据显示，2025年，德美医疗营收和净利润均实现较快增长。在当 前爱博医疗业绩增速放缓的背景下，此次收购能否为公司注入新的增长动力，记者将持续关注。 爱博医疗最新公告显示，公司拟使用并购贷款及自有资金收购德美医疗68.31%股权，本次交易对价为6.83亿元。公司支付 第一期股转款后，本次交易涉及的德美医疗股权将全部完成办理工商变更登记，公司将享有作为目标公司股东的全部权利 和权益，德美医疗将成为公司控股子公司，纳入公司合并报表范围。 公告显示，德美医 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：公子豹资本圈 格力电器晚间公告在各种平台上炸开了锅。 2月25日晚间，格力电器公告称，第一大股东珠海明骏（高瓴资本旗下投资主体）计划在3个月内，通过 大宗交易减持不超过1.12亿股，占总股本的2%。 按公告当日收盘价38.49元/股计算，本次套现金额约43亿元。这是高瓴自2019年入主格力六年来首次减 持，资金明确用于偿还并购贷款。 资金压力与被动选择 结合其杠杆收购的背景看，此次减持更像是一次被动的"财务安排"： 回溯历史，2019年高瓴以46.17元/股、总价416.62亿元受让格力15%股份，其中约200亿元来自银行贷 款。 按7年周期计算，贷款及利息在2026年底面临集中偿还压力，本息合计或超250亿元。 现金奶牛也终归是一头牛。尽管高瓴六年来累计获得分红超130亿元，但仍不足以覆盖200多亿的贷款本 金，更不用说利息，因此只能通过减持股票来补足差额。 马上面临"七年之痒"。一场"苦涩"的联姻与长跑之后，不知道男女主角董明珠和张磊作何感想！ 董姐姐还是那个董姐姐。从张磊的荷包看，这笔投资收益率显然并不理想，可谓"赚了股息， ...

据知情人士透露，私募巨头 KKR 集团（Kohlberg Kravis Roberts & Co. L.P.）于 2026 年 2 月 23 日正式同意收购东南亚 K-12 教育运营商 XCL 教育控股（XCL Education Holdings）的多数股权，此次交易对该公司的估值约为 13 亿美元。 作为全球私募股权行业的标杆企业，KKR 成立于 1976 年，总部位于美国纽约，是杠杆收购（LBO）模式的开创者，与黑石、凯雷、德 州太平洋集团并称「全球四大 PE 巨头」。截至 2024 年 9 月底，其管理的资产总额达 6244 亿美元，业务覆盖私募股权、信贷、基础设 施、房地产等多个领域，2010 年在纽交所上市（股票代码：KKR），当前总市值约 821.74 亿美元。 消息人士称，KKR 在竞标中击败了其他投资机构，拿下了 TPG 集团持有的 XCL 教育相关股权，但未予披露具体持股比例。由于相关信 息尚未公开，上述人士要求匿名，并表示该交易尚待监管部门审批及交割条件达成。KKR 与 TPG 的相关代表均拒绝就此置评。另据知 情人士 2025 年 12 月透露，华平投资（Warburg Pincus） ...

Group 1: Core Insights - The core event is the change of controlling shareholder of Aolian Electronics, with Tianjin Chaocheng Innovation Technology Co., Ltd. acquiring 19.09% of shares for 6.3 billion yuan at a price of 19.29 yuan per share, leading to a shift in actual control to Zhang Yan [1] - The acquisition raises concerns about the stability of the funding chain, as the acquiring company was established recently in October 2024 and relies on leverage for funding [1] Group 2: Stock Performance - Aolian Electronics' stock price experienced significant volatility, with a 4.72% increase on February 9, 2026, following the announcement, but subsequently fell by 1.87% and 1.40% on the following days, closing at 17.60 yuan [2] - The stock's trading range reached 8.42%, with a turnover rate of 4.72% on February 9, indicating active trading [2] - The current stock price is below the acquisition price of 19.29 yuan per share, reflecting market concerns regarding the leveraged acquisition and the company's fundamentals [2] Group 3: Financial Performance - Aolian Electronics expects a net loss of 60 million to 68 million yuan for the year 2025, primarily due to provisions for investor lawsuits affecting non-recurring gains and losses [3] - Despite a slight revenue increase of 1.08% in the first three quarters of 2025, the company's main business profitability has not improved significantly, relying on non-recurring gains for support [3] - The company has faced continuous pressure on its performance, with a reported loss of 8.506 million yuan in 2024 and a decline in net profit for three consecutive years [3] Group 4: Analyst Opinions - Analysts note that the automotive industry is highly competitive, with Aolian Electronics' revenue growth of only 1.08% in the first three quarters of 2025 falling short of the industry growth rate, where new energy vehicle production and sales increased by over 40% in the first half of 2025 [4] - The company's R&D expenses decreased by 15% year-on-year, indicating pressure from technological iterations amid the electrification transition [4] - The new controlling shareholder's focus on semiconductors may suggest potential asset injection or business transformation, but the lack of clarity regarding the actual controller's background adds uncertainty [4]

登录新浪财经APP 搜索【信披】查看更多考评等级 智通财经记者 | 陶知闲 奥联电子（维权）（300585.SZ）的一纸公告揭开了控股权变更大幕。 这家公司控股股东广西瑞盈资产管理有限公司（下称"瑞盈资产"）与天津潮成创新科技有限公司（下称"潮成创新"）签署《股份转让协议》，后者以19.29 元/股的价格受让3266.67万股股份，占公司总股本的19.09%，合计对价6.3亿元。交易完成后，奥联电子控股股东将由瑞盈资产变更为潮成创新，实际控制人 也从钱明飞切换至张雁。 智通财经记者发现，这场看似常规的股权腾挪，暗藏多重悬念：收购方潮成创新成立仅一年，其控股股东潮成集团同样是2024年10月才成立的 "新面孔"； 收购资金依赖贷款下的杠杆；而奥联电子自身正深陷业绩萎靡、财务承压、历史处罚等多重困境。 在汽车行业供应链重构、市场竞争白热化的背景下，这场 "新主新局" 能否带领奥联电子走出泥潭？ 19.09% 股份易主，杠杆收购背后的资本迷局 在上市公司业绩持续承压、行业处于调整期的节点，突然出现一家成立仅一年的企业接手近两成股权，且采用杠杆收购模式，这在资本市场并不常见。 奥联电子本次股份转让的核心交易细节清晰但 ...

摩根大通等 银行已开始发售为收购艺电而筹集200亿美元的债务融资，这笔资金将支持史上规模最大的 杠杆收购案——对 游戏巨头艺电的私有化收购。据知情人士透露，中东、亚洲及欧洲的小型银行正积 极买入该视频游戏制造商价值约30亿美元的A类定期贷款。 此次发售过程将持续至2月底，承销银行有 权根据市场情况灵活调整A类定期贷款的规模。 ...

Core Viewpoint - KKR has announced a new round of investment in Sylvan, a leading global mushroom cultivation and fungal biotechnology company, through its managed dollar and RMB funds, including its first RMB fund [1] Group 1: Company Overview - Sylvan is backed by Jiangsu Yuguan Modern Agricultural Technology Co., Ltd., founded by Huang Jianguang, known as the "Mushroom King" in China [2] - Huang Jianguang started his mushroom business in the 1980s, leading to significant market share in canned mushrooms, with his company producing 68% of the canned mushrooms exported from China to the U.S. [4] - Jiangsu Yuguan was established in 2010 to cultivate high-quality fresh white mushrooms, which account for 40% of the edible mushroom market globally [4] Group 2: Investment Details - KKR's initial investment in Jiangsu Yuguan was approximately 2 billion RMB, which helped the company become the largest single production unit for white mushrooms globally [4] - KKR facilitated the full acquisition of Sylvan and its research laboratories by Jiangsu Yuguan, expanding its global operational footprint [5] - The latest investment aims to support Sylvan's expansion plans, including capacity enhancement, R&D strengthening, and product line diversification in the rapidly industrializing Asian mushroom and bioproducts market [5] Group 3: KKR's Investment Strategy - KKR's assets under management (AUM) reached $723 billion (approximately 5 trillion RMB) as of September 30, 2025, with a diverse portfolio across private equity, private credit, and real estate [7] - KKR has been actively increasing its investments in Chinese assets, including the establishment of its first onshore RMB fund in Shanghai [6][7] - The firm recently completed a $2.5 billion (approximately 17 billion RMB) fundraising for an Asian private credit fund, focusing on high-quality credit assets in the Asia-Pacific region [7][8]

Group 1 - Paramount's Skydance plans to nominate directors to the Warner Bros. Discovery (WBD) board to oppose WBD's $82.7 billion acquisition deal with Netflix and promote its own acquisition proposal [1][3] - Paramount has filed a lawsuit demanding WBD disclose financial information related to the deal, including evaluations of WBD's global television network business [1][3] - Paramount's CEO David Ellison stated that the outcome may depend on shareholder votes at the annual meeting unless WBD decides to negotiate under the Netflix merger agreement [3][4] Group 2 - Paramount proposed an acquisition offer of $108.4 billion for WBD, while Netflix's offer includes a personal guarantee of $40 billion from Oracle co-founder Larry Ellison [3][4] - The Netflix deal offers $23.25 per share in cash, stock, and equity in the split-off Paramount global television network, while Paramount's offer is $30 per share in cash [4] - WBD's board previously rejected Paramount's offer, labeling it as the "largest leveraged buyout in history," and indicated that accepting Paramount's bid would incur $4.7 billion in costs [4]

华纳兄弟探索公司董事会拒绝了派拉蒙天舞修订后的收购要约，对派拉蒙千亿杠杆收购的可行性存疑。 周三华纳兄弟董事会在致股东信中表示，相比Netflix以每股27.75美元现金加股票收购其影视和流媒体业务的方案，派拉蒙的提议存在重大风险和 不确定性。 尽管亿万富翁Larry Ellison承诺个人担保404亿美元股权融资，支持派拉蒙以每股30美元的现金发起敌意收购，但华纳兄弟怀疑派拉蒙能否完成交 易，依旧选择拒绝修订后的收购要约。 华纳兄弟第七大股东Pentwater资管公司警告称，董事会若不与派拉蒙接洽是在"犯错"，并威胁在下次选举中反对所有董事会成员并投票反对 Netflix合并。 华纳兄弟股价周三涨0.33%至28.55美元，仍低于派拉蒙的报价。 融资结构引发交易风险担忧 派拉蒙的融资安排仍是关键症结。 华纳兄弟董事会重申了对超过500亿美元借款要求的担忧。据华纳兄弟在信中所述，市值约140亿美元的派拉蒙正在尝试一项需要946.5亿美元债务 和股权融资的收购，几乎是其总市值的七倍。 华纳兄弟表示： 如此巨额的债务融资以及派拉蒙报价的其他条款加剧了交易失败风险，尤其是与Netflix合并的确定性相比。目标公司或 ...